Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2001
10/18/2001WO2001077101A1 Chemical compounds
10/18/2001WO2001077100A2 Benzoamide piperidine compounds as substance p antagonists
10/18/2001WO2001077086A1 SUBSTITUTED LACTAMS AS INHIBITORS OF Aβ PROTEIN PRODUCTION
10/18/2001WO2001077085A1 Quinazoline compounds
10/18/2001WO2001077080A2 Pyrazole compounds having anti proliferative activity
10/18/2001WO2001077079A2 Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade
10/18/2001WO2001077075A2 Inhibitors of inflammation and reperfusion injury
10/18/2001WO2001076629A1 Soluble beta amyloid precursor protein secretion promoters
10/18/2001WO2001076600A2 Inhibition of cytokine generation
10/18/2001WO2001027087A3 Process for making boc-protected 3-aminohydantoins/thiohydantoins and 3-aminodihydrouracils/dihydrothiouracils
10/18/2001WO2001025213B1 Pyrrolo imidazole derivatives and their use as medicaments
10/18/2001WO2000071518A3 Heterocyclic analgesic compounds and their use
10/18/2001US20010031895 Intermediate p-cyclopropanoyl cumene compounds and derivatives, optionally having a 3-hydroxy group; 1-(benzoylalkyl)-4-(diphenylmethoxy)-piperidine compounds and 1-(a-hydroxybenzylalkyl)-4-(diphenylalkenyl)-piperidines
10/18/2001US20010031894 Metal-catalyzed arylations of hydrazines, hydrazones, and related substrates
10/18/2001US20010031875 Optically active ionic liquid
10/18/2001US20010031869 Formation of bond between nitrogen atom of acridan ring and carbon atom of another aromatic or heteroaromatic ring compound; assays for peroxidase enzymes and enzyme inhibitors and in assays employing enzyme-labeled specific binding pairs
10/18/2001US20010031780 Compounds such as (s,s)1-(2-amino-3,3-dimethyl-butyryl)-2,5-dihydro-1h-pyrrole-2 -carbonitrile administered as antidiabetic agents; dipeptidyl peptidase-iv (dpp-iv)
10/18/2001US20010031778 Triazole antifungal agent
10/18/2001US20010031768 Triazole antifungal agent
10/18/2001US20010031765 Antiviral compounds
10/18/2001US20010031757 Administering compounds such as 3-(2-phenylethylamino)-6-methyl-1-(2-amino-6-methyl-5-methylene -carboxamidomethylpyridi nyl)-2-pyrazinone, N'-((1-(Aminoiminomethyl)4-piperidinyl) methyl)-N-(3,3- diphenylpropionyl)-L-proline amide
10/18/2001US20010029959 Nicotine salts having improved taste, process for their preparation and their use
10/18/2001DE10016893A1 Substituierte Phenyluracile Substituted Phenyluracils
10/18/2001CA2405413A1 Inhibition of cytokine generation
10/18/2001CA2405306A1 Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade
10/18/2001CA2405163A1 Soluble beta amyloid precursor protein secretion promoters
10/18/2001CA2405089A1 Benzoamide piperidine containing compounds and related compounds
10/18/2001CA2404273A1 Substituted lactams as inhibitors of a.beta. protein production
10/18/2001CA2403365A1 Quinazoline compounds
10/18/2001CA2403012A1 Chemical compounds
10/17/2001EP1146045A1 Piperidine derivatives having effects on serotonin related systems
10/17/2001EP1146044A1 CNS active cyclobuta-indole carboxamide derivatives, processes for their preparation and pharmaceutical compositions containing them
10/17/2001EP1144407A1 Cyclic guanidine derivatives and their use as pesticides
10/17/2001EP1144405A1 Triazole compounds with dopamine-d3-receptor affinity
10/17/2001EP1144404A1 Piperidinylquinolines as protein tyrosine kinase inhibitors
10/17/2001EP1144403A1 Substitued pyrazoles as p38 kinase inhibitors
10/17/2001EP1144402A2 Substituted oximes and hydrazones as neurokinin antagonists
10/17/2001EP1144390A2 Kinase inhibitors
10/17/2001EP1144388A1 Acyl derivatives which treat vla-4 related disorders
10/17/2001EP1144384A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/17/2001EP1144381A2 Substituted benzo[de]isoquinoline-1,3-diones
10/17/2001EP1144368A2 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors
10/17/2001EP1143991A2 Inhibitors of h+k+ -atpase
10/17/2001EP1143959A2 Antifungal activity of dicationic molecules
10/17/2001EP1143946A2 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis
10/17/2001EP0950049B1 Diphenyl alkyl-tetrahydropyridines, process for their preparation, and pharmaceutical compositions containing them
10/17/2001EP0754682B1 Aminostilbazole derivative and medicine
10/17/2001EP0709373B1 Pyrrolidine derivative
10/17/2001EP0652871B1 Benzodiazepine derivatives
10/17/2001CN1318065A Novel salt form of pantoprazole
10/17/2001CN1318059A Isoquinolines as urokinase inhibitors
10/17/2001CN1318056A Pyridinum derivatives for management of aging-related and diabetic vascular complications, process for their prepn. and therepeutic uses thereof
10/17/2001CN1318055A Pyridine ketones useful as herbicides
10/17/2001CN1318053A Cyclopentanoue dihydropyridine compounds useful as potassium channel openers
10/17/2001CN1318052A Arylpiperazine derivatives useful as uroselective alpha-adrenoceptor blockers
10/17/2001CN1317968A 2-bustituted-1-piperidyl benzimidazole compounds as or/1-receptor agonists
10/17/2001CN1317966A Utilization of aryl (or heteroaryl) azolylcarbinol derivatives in prepn. of medicament for treating troubles mediated by excess of substance P
10/17/2001CN1317965A Compounds having IgE affecting properties
10/17/2001CN1073111C Process for preparation of 2,3-pyridinedicarboximides
10/17/2001CN1073107C Process for 2-substituted benzo [b] thiophene compounds and intermediates thereof
10/17/2001CN1073103C Compounds and compsns. for treating diseases associated with tryptase activity
10/17/2001CN1073080C Process for mfg. mixed anhydrides
10/16/2001US6303793 Intermediates for cyclin-dependent kinase inhibitors
10/16/2001US6303788 Process for preparing omeprzole
10/16/2001US6303787 Intermediates and an improved process for the preparation of Omeprazole employing the said intermediates
10/16/2001US6303639 Propanolamine derivatives substituted by heterocyclic radicals, processes for their preparation, pharmaceuticals comprising these compounds and their use
10/16/2001US6303638 Substituted pyridines as modulators of the mammalian neuronal nicotinic acetylcholine receptor
10/16/2001US6303633 Heteroaryl amines as novel acetylcholinesterase inhibitors
10/16/2001US6303628 Bicycliccarbonyl indole compounds as anti-inflammatory/analgesic agents
10/16/2001US6303627 For therapy of physiological and psychological disorders
10/16/2001US6303620 Compounds with growth hormone releasing properties
10/16/2001US6303615 2,3 disubstituded-4(3H)-quinazolinones
10/16/2001US6303611 For therapy of hyperalgesis
10/16/2001US6303610 Method of treating gout with certain indole compounds
10/16/2001US6303608 2-{4-[4-(4,5-dichloro-2-methylimidazol-1-yl)butyl]-1-piperazinyl}-5-fluoropyrimidine, its preparation and its therapeutic use
10/16/2001US6303603 3-oxo-2(H)-1,2,4-triazine derivatives as ligands of 5 HT1A receptors
10/16/2001US6303602 Useful as analgesic, anesthetic, anti-inflammatory or neuroprotective agent, or for therapy of arthritis, stroke of functional bowel disease
10/16/2001US6303601 Arylgycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
10/16/2001US6303600 Substituted azabicyclic compounds
10/16/2001US6303593 For therapy human immunodeficiency virus infection, aquired immunodeficiency syndrome (aids), inflammatory and immunoregulatory disorder or disease, asthma, allergic rhinitis, dermatitis, conjunctivitis, atherosclerosis
10/16/2001US6302837 Benzothiophene, benzofuran and indole compounds
10/16/2001CA2089349C New pyrolidine derivatives, process for their preparation and pharmaceutical composition holding same
10/16/2001CA2025301C New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase
10/11/2001WO2001074815A2 Phenyl-substituted imidazopyridines
10/11/2001WO2001074814A1 Phenyl-substituted indolizine derivatives and their use as histamine h3 ligands
10/11/2001WO2001074813A2 METHOD FOR USING 2- OR 3-ARYL SUBSTITUTED IMIDAZO[1,2-a] PYRIDINES AS H3 ANTAGONISTS
10/11/2001WO2001074810A2 Method for using 2-aryloxyalkylaminobenzoxazoles and 2-aryloxyalkylaminobenzothiazoles as h3 antagonists
10/11/2001WO2001074806A1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
10/11/2001WO2001074805A1 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
10/11/2001WO2001074804A1 Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatement of pain
10/11/2001WO2001074803A1 Method for preparing 3-(4-hydroxy-1h-indol-ylmethyl)-pyridinium compounds using an aldolisation reaction
10/11/2001WO2001074796A1 SUCCINOYLAMINO HETEROCYCLES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
10/11/2001WO2001074791A1 Diazepane derivatives or salts thereof
10/11/2001WO2001074790A2 Novel compounds for enhancing chemotherapy
10/11/2001WO2001074783A1 Cyclic lactams as inhibitors of a βετα protein production
10/11/2001WO2001074775A1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
10/11/2001WO2001074774A1 Ethylenediamine derivatives
10/11/2001WO2001074773A2 Phenyl-substituted indoles as histamine h3-receptor antagonists
10/11/2001WO2001074771A1 Pyrrole-2,5-dione derivatives for the treatment of diabetes
10/11/2001WO2001074769A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
1 ... 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 ... 1080